Moyamoya disease emerging as an immune-related angiopathy

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive arterial narrowing and fragile collateral vessels.
• The etiology of MMD remains largely unknown.
• RNF213 (mysterin) is a known MMD susceptibility gene, but its low penetrance indicates additional factors are involved.

Purpose of the Study:

• To explore the role of immune-related responses as potential second hits in triggering MMD onset.
• To synthesize recent molecular and clinical findings linking RNF213, immunity, and MMD.

Main Methods:

• Review of recent molecular studies on RNF213 function.
• Analysis of clinical reports associating MMD with infections and autoimmune disorders.

Main Results:

• RNF213 functions as a key antimicrobial protein involved in immune responses.
• Clinical data increasingly links moyamoya angiopathy (MMA) to infectious or autoimmune conditions.

Conclusions:

• Immune-related responses are implicated as critical second hits in the pathogenesis of MMD.
• This provides a novel perspective on MMD etiology, integrating genetic predisposition with immune system triggers.